These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 29309301

  • 1. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
    Kim SJ, Akita M, Sung YN, Fujikura K, Lee JH, Hwang S, Yu E, Otani K, Hong SM, Zen Y.
    Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas.
    Sawada R, Ku Y, Akita M, Otani K, Fujikura K, Itoh T, Ajiki T, Fukumoto T, Kakeji Y, Zen Y.
    Histopathology; 2018 Aug; 73(2):259-272. PubMed ID: 29675965
    [Abstract] [Full Text] [Related]

  • 3. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
    Della Torre G, Pasquini G, Pilotti S, Alasio L, Civelli E, Cozzi G, Milella M, Salvetti M, Pierotti MA, Severini A.
    Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
    [Abstract] [Full Text] [Related]

  • 4. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM.
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [Abstract] [Full Text] [Related]

  • 5. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, Carpino G.
    Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
    [Abstract] [Full Text] [Related]

  • 6. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K, Akita M, Ajiki T, Fukumoto T, Itoh T, Zen Y.
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
    Schlitter AM, Born D, Bettstetter M, Specht K, Kim-Fuchs C, Riener MO, Jeliazkova P, Sipos B, Siveke JT, Terris B, Zen Y, Schuster T, Höfler H, Perren A, Klöppel G, Esposito I.
    Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
    [Abstract] [Full Text] [Related]

  • 9. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.
    Simbolo M, Fassan M, Ruzzenente A, Mafficini A, Wood LD, Corbo V, Melisi D, Malleo G, Vicentini C, Malpeli G, Antonello D, Sperandio N, Capelli P, Tomezzoli A, Iacono C, Lawlor RT, Bassi C, Hruban RH, Guglielmi A, Tortora G, de Braud F, Scarpa A.
    Oncotarget; 2014 May 15; 5(9):2839-52. PubMed ID: 24867389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.
    Akita M, Sofue K, Fujikura K, Otani K, Itoh T, Ajiki T, Fukumoto T, Zen Y.
    HPB (Oxford); 2019 Feb 15; 21(2):226-234. PubMed ID: 30170977
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas.
    Sasaki M, Sato Y, Nakanuma Y.
    Pathol Res Pract; 2024 Jan 15; 253():155061. PubMed ID: 38154357
    [Abstract] [Full Text] [Related]

  • 15. Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.
    Rhee H, Ko JE, Chung T, Jee BA, Kwon SM, Nahm JH, Seok JY, Yoo JE, Choi JS, Thorgeirsson SS, Andersen JB, Lee HS, Woo HG, Park YN.
    Liver Int; 2018 Jan 15; 38(1):113-124. PubMed ID: 28608943
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases.
    Jang S, Chun SM, Hong SM, Sung CO, Park H, Kang HJ, Kim KP, Lee YJ, Yu E.
    Mod Pathol; 2014 May 15; 27(5):731-9. PubMed ID: 24186137
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
    Castiglione R, Alidousty C, Holz B, Wagener S, Baar T, Heydt C, Binot E, Zupp S, Kron A, Wolf J, Merkelbach-Bruse S, Reinhardt HC, Buettner R, Schultheis AM.
    Mod Pathol; 2019 May 15; 32(5):627-638. PubMed ID: 30459450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.